Hepatic glucose metabolism following inhibition of glycogen phosphorylase in the high fat fed rat model of type 2 diabetes

被引：0
|
作者：
Fosgerau, K
Rakipovski, G
Petersen, H
Pedersen, KE
Larsen, MO
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A575 / A575
页数：1
相关论文
共 50 条
  • [41] Effects of fisetin supplementation on hepatic lipogenesis and glucose metabolism in Sprague-Dawley rats fed on a high fat diet
    Cho, Yoonsu
    Chung, Ji Hyung
    Do, Hyun Ju
    Jeon, Hyun Ju
    Jin, Taewon
    Shin, Min-Jeong
    FOOD CHEMISTRY, 2013, 139 (1-4) : 720 - 727
  • [42] Distribution of abdominal fat and glucose metabolism in older, obese adults at risk for type 2 diabetes
    Coker, RH
    Hays, NP
    Williams, RH
    Brown, AD
    Dennis, RA
    Freeling, SA
    Sullivan, DH
    Kortebein, PM
    Evans, WJ
    DIABETES, 2005, 54 : A443 - A444
  • [43] EARLY IMPROVEMENT OF GLUCOSE METABOLISM IN TYPE 2 DIABETES MELLITUS FOLLOWING SLEEVE GASTRECTOMY
    Spivak, H.
    Goldstein, N.
    Shwartz, E. Weiss
    Goitein, D.
    Rubin, M.
    OBESITY SURGERY, 2012, 22 (08) : 1157 - 1157
  • [44] The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction
    Baker, David J.
    Greenhaff, Paul L.
    MacInnes, Alan
    Timmons, James A.
    DIABETES, 2006, 55 (06) : 1855 - 1861
  • [45] Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
    Cusi, Kenneth
    Bril, Fernando
    Barb, Diana
    Polidori, David
    Sha, Sue
    Ghosh, Atalanta
    Farrell, Kristin
    Sunny, Nishanth E.
    Kalavalapalli, Srilaxmi
    Pettus, Jeremy
    Ciaraldi, Theodore P.
    Mudaliar, Sunder
    Henry, Robert R.
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 812 - 821
  • [46] Ezetimibe improves glucose metabolism by ameliorating hepatic function in Japanese patients with type 2 diabetes
    Ichimori, Shinji
    Shimoda, Seiya
    Goto, Rieko
    Matsuo, Yasuto
    Maeda, Takako
    Furukawa, Noboru
    Kawashima, Junji
    Kodama, Shoko
    Sekigami, Taiji
    Isami, Satoshi
    Nishida, Kenro
    Araki, Eiichi
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (02) : 179 - 184
  • [47] Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes
    Md. Kamrul Hasan Chowdhury
    Nigel Turner
    Nicholas L. Bentley
    Abhirup Das
    Lindsay E. Wu
    Dulama Richani
    Sonia Bustamante
    Robert B. Gilchrist
    Margaret J. Morris
    Peter R. Shepherd
    Greg C. Smith
    Scientific Reports, 7
  • [48] Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes
    Chowdhury, Md. Kamrul Hasan
    Turner, Nigel
    Bentley, Nicholas L.
    Das, Abhirup
    Wu, Lindsay E.
    Richani, Dulama
    Bustamante, Sonia
    Gilchrist, Robert B.
    Morris, Margaret J.
    Shepherd, Peter R.
    Smith, Greg C.
    SCIENTIFIC REPORTS, 2017, 7
  • [49] The intake of potatoes and glucose metabolism in subjects at high risk for Type 2 diabetes
    Ylonen, S. K.
    Virtanen, S. M.
    Groop, L.
    DIABETIC MEDICINE, 2007, 24 (09) : 1049 - 1050
  • [50] Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib
    Krishnamurthy, K. A.
    Rutten, M. G. S.
    Hoogerland, J. A.
    van Dijk, T. H.
    Bos, T.
    Koehorst, M.
    de Vries, M. P.
    Kloosterhuis, N. J.
    Havinga, H.
    Schomakers, B. V.
    van Weeghel, M.
    Wolters, J. C.
    Bakker, B. M.
    Oosterveer, M. H.
    MOLECULAR METABOLISM, 2024, 79
12345